ARCH Venture Management as of Sept. 30, 2022
Portfolio Holdings for ARCH Venture Management
ARCH Venture Management holds 10 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Karuna Therapeutics Ord | 38.3 | $295M | 1.3M | 224.93 | |
| Eqrx | 23.3 | $180M | 36M | 4.95 | |
| Denali Therapeutics (DNLI) | 14.6 | $113M | 3.7M | 30.69 | |
| Erasca (ERAS) | 11.2 | $86M | 11M | 7.80 | |
| Verve Therapeutics (VERV) | 8.9 | $69M | 2.0M | 34.35 | |
| Revolution Healthcar Aq Corp | 1.7 | $13M | 1.4M | 9.83 | |
| Singular Genomics Systems In | 1.2 | $9.5M | 3.8M | 2.50 | |
| Unity Biotechnology (UBX) | 0.5 | $4.0M | 10M | 0.40 | |
| Metacrine Ord | 0.2 | $1.4M | 2.9M | 0.48 | |
| Rubius Therapeutics | 0.0 | $152k | 350k | 0.43 |
